Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PHAT
Stock Latest News
Company Announcements
Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up
11d ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals price target raised to $25 from $20 at Guggenheim
16d ago
PHAT
Premium
Ratings
Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating
16d ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals price target raised to $13 from $12 at Goldman Sachs
17d ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals reports Q4 EPS (8c), consensus (19c)
17d ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals sees FY26 net revenues $320M9$345M, consensus $312.56M
17d ago
PHAT
Premium
Company Announcements
Phathom Pharmaceuticals Announces $130 Million Public Offering
2M ago
8K
PHAT
Premium
The Fly
Phathom Pharmaceuticals 6.875M share Secondary priced at $16.00
2M ago
PHAT
Premium
The Fly
Closing Bell Movers: Defense stocks surge on Trump military budget comments
2M ago
FC
GD
Premium
The Fly
Phathom raises FY25 revenue view to $174.5M-$175.5M from $170M-$175M
2M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals announces common stock offering, no amount given
2M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals files automatic mixed securities shelf
2M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals sees Q4 revenue $57M-$58M, consensus $56.16M
2M ago
PHAT
Premium
The Fly
Needham ups Vaxcyte target, adds to Conviction List
2M ago
PCVX
PHAT
Premium
Stock Analysis & Ideas
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
3M ago
LXEO
PHAT
Premium
The Fly
Phathom Pharmaceuticals initiated with a Strong Buy at Raymond James
3M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals initiated with an Equal Weight at Barclays
3M ago
PHAT
Premium
The Fly
Phathom announces first patient dosed in Phase 2 pHalcon-EoE-201 trial
4M ago
PHAT
Premium
Company Announcements
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
4M ago
8K
PHAT
Premium
Company Announcements
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
4M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals price target raised to $22 from $17 at Craig-Hallum
5M ago
PHAT
Premium
The Fly
Phathom Pharmaceuticals price target raised to $26 from $20 at H.C. Wainwright
5M ago
PHAT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
